Overview
Sean X Luo, MD, PhD, is Assistant Professor of Clinical Psychiatry at Columbia University Division on Substance Use Disorders, and a Research Scientist at the New York State Psychiatric Institute. He attended the University of Chicago for his undergraduate degree in physics and mathematics and completed his training through the Medical Scientist Training Program at Columbia University, in computational neuroscience. He completed psychiatry training at Columbia University/New York State Psychiatric Institute and a NIDA funded T32 research fellowship in Addiction Psychiatry at Columbia.
Academic Appointments
- Assistant Professor of Clinical Psychiatry
Administrative Titles
- Research Scientist, New York State Psychiatric Institute
Languages
- Chinese
Gender
- Male
Credentials & Experience
Education & Training
- BS, 2003 Physics, University of Chicago
- MD, 2010 Columbia University Vagelos College of Physicians and Surgeons
- PhD, 2010 Computational and Theoretical Neuroscience, Columbia University
Research
Dr. Luo’s current research interest lies at the interface of statistics, artificial intelligence, neuroscience and addiction psychiatry. Active research projects focus on bottom-up and top-down approaches to develop new algorithms and models to better match patients with substance use disorders to treatment. There is also significant interest in developing novel biomarkers and signal processing methods to extract predictive information from neuroscience-inspired human research methods.
Grants
- Individual Level Predictive Modeling of Opioid Use Disorder Treatment Outcome (NIH Heal Initiative)
(Federal Gov)
Feb 15, 2020 – Feb 15, 2022 - Electroretinogram: a new human biomarker for smoking cessation treatment
(Federal Gov)
Jul 1 2017 - July 1 2022
Selected Publications
- Luo SX, Wall M, Covey L, Hu MC, Levin FR, Nunes EV and Winhusen T. Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with Attention-Deficit Hyperactivity Disorder (ADHD) American Journal of Drug and Alcohol Dependence, 2018;44(6):653-659
- Luo SX, Covey L, Hu MC, Levin FR, Nunes EV and Winhusen T. Toward personalized smoking-cessation treatment: using a predictive modeling approach to guide decisions regarding stimulant medication treatment of attention-deficit/hyperactivity disorder (ADHD) in smokers, American Journal on Addictions, 2015, 4:348-56. PMID: 25659348
- Luo SX, Martinez D, Carpenter K, Silfstein M and Nunes EV. Multimodal predictive modeling of individual treatment outcome in cocaine dependence with combined neuroimaging and behavioral predictors, Drug and Alcohol Dependence, 2014, 143:29-35. PMID: 25108585
For a complete list of publications, please visit PubMed.gov